Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

We are about to publish the LARGEST human ivermectin-cancer study ever conducted. After 6 months, many patients reported their cancer was GONE. HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types.

NicHulscher's profile picture

Nicolas Hulscher, MPH

260,354 subscribers

1,685,644 Aufrufe • vor 3 Monaten •via X (Twitter)

Gesundheit & WellnessWissenschaft & Technologie
LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith
1:30

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

Nicolas Hulscher, MPH

19,219 Aufrufe • vor 2 Monaten

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.
1:44

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,047,720 Aufrufe • vor 2 Monaten

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.
0:37

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

5,197,157 Aufrufe • vor 3 Monaten

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.
1:15

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

89,829 Aufrufe • vor 4 Monaten

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.
1:01

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.

Whiplash347

26,006 Aufrufe • vor 3 Monaten

Ivermectin exerts over TWELVE distinct anti-cancer mechanisms across more than TWELVE cancer types — according to HUNDREDS of studies. And finally, the NIH has officially acknowledged this and launched studies on ivermectin’s ability to eliminate cancer cells.
1:01

Ivermectin exerts over TWELVE distinct anti-cancer mechanisms across more than TWELVE cancer types — according to HUNDREDS of studies. And finally, the NIH has officially acknowledged this and launched studies on ivermectin’s ability to eliminate cancer cells.

Nicolas Hulscher, MPH

244,748 Aufrufe • vor 4 Monaten

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH
0:37

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 Aufrufe • vor 2 Monaten

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.
1:20

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

Nicolas Hulscher, MPH

22,556 Aufrufe • vor 3 Monaten

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Nicolas Hulscher, MPH

100,286 Aufrufe • vor 2 Monaten

We found 84% of cancer patients taking ivermectin and mebendazole declared their cancer was either COMPLETELY GONE, SHRUNK, or STOPPED SPREADING after 6 months. This explains why the CIA CLASSIFIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer.
1:15

We found 84% of cancer patients taking ivermectin and mebendazole declared their cancer was either COMPLETELY GONE, SHRUNK, or STOPPED SPREADING after 6 months. This explains why the CIA CLASSIFIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer.

Nicolas Hulscher, MPH

75,287 Aufrufe • vor 1 Monat

We found 84% of cancer patients taking ivermectin and mebendazole for 6 months declared their cancer was either COMPLETELY GONE, REGRESSED, or STOPPED SPREADING. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.
0:58

We found 84% of cancer patients taking ivermectin and mebendazole for 6 months declared their cancer was either COMPLETELY GONE, REGRESSED, or STOPPED SPREADING. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.

Nicolas Hulscher, MPH

2,378,619 Aufrufe • vor 2 Monaten

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️
0:37

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️

Catturd ™

251,238 Aufrufe • vor 21 Tagen

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).

Joe Tippens

30,145 Aufrufe • vor 2 Monaten

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.
0:58

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.

Nicolas Hulscher, MPH

178,494 Aufrufe • vor 12 Tagen

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.
1:15

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.

Nicolas Hulscher, MPH

49,510 Aufrufe • vor 2 Tagen

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.
0:58

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.

Nicolas Hulscher, MPH

56,686 Aufrufe • vor 4 Monaten

It’s no wonder the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics SUPPRESS cancer growth.... Our study found 84.4% of cancer patients taking ivermectin + mebendazole declared their cancer either DISAPPEARED, REGRESSED, or STOPPED SPREADING.
0:36

It’s no wonder the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics SUPPRESS cancer growth.... Our study found 84.4% of cancer patients taking ivermectin + mebendazole declared their cancer either DISAPPEARED, REGRESSED, or STOPPED SPREADING.

Nicolas Hulscher, MPH

44,300 Aufrufe • vor 1 Monat

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.
1:18

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.

Nicolas Hulscher, MPH

436,393 Aufrufe • vor 2 Monaten

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.
1:34

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

Joe Tippens

55,953 Aufrufe • vor 2 Monaten

🚨LANDMARK STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% — With ZERO Toxicity Ivermectin nanocapsules DESTROY glioblastoma in animal models at doses LOWER than standard human doses. These findings align with ivermectin’s 14 distinct anti-cancer mechanisms.
0:58

🚨LANDMARK STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% — With ZERO Toxicity Ivermectin nanocapsules DESTROY glioblastoma in animal models at doses LOWER than standard human doses. These findings align with ivermectin’s 14 distinct anti-cancer mechanisms.

Nicolas Hulscher, MPH

164,490 Aufrufe • vor 8 Monaten